Our lab focuses on developing gene therapies for diseases associated with mitochondrial dysfunctions. Currently, we are focusing on diseases including Leigh syndrome, a primary mitochondrial disease, and NF2-related schwannomatosis. We combine state-of-the-art gene delivery platforms with advanced computational approaches to develop precise, efficient, and safe therapeutic strategies to accelerate discovery and translation. By integrating experimental approaches with bioinformatics analysis and predictions, our team aims to overcome the current limitations of gene therapy and open new frontiers in personalized medicine.

Interested in our research? Please contact us